Medicare Advantage Gets a $13 Billion Bump. Where Are the Guardrails?

I have read enough government rate notices to recognize the vibe: warm copier toner, cold confidence, and a strong belief the public will not ask follow-up questions.

CMS released its Calendar Year 2027 Medicare Advantage and Part D Rate Announcement. Wall Street heard “more money.” Seniors heard “please do not change my plan again.” Taxpayers heard a familiar tab opening, payable on demand.

The headline number: 2.48% and about $13 billion

CMS says the finalized Medicare Advantage payment policies are projected to produce a net average increase of 2.48%, or over $13 billion in additional payments to Medicare Advantage plans in 2027.

CMS also says that if you account for the expected risk score trend in Medicare Advantage, driven by population changes and coding practices, the overall increase comes out to 4.98%.

Markets did what markets do. A Reuters report noted major insurer stocks jumped on April 7 after the announcement, with UnitedHealth, Humana, CVS, and Elevance moving up.

What changed (and what did not)

The real story lives in the fine print, where CMS tries to talk about integrity without picking a fight with every plan that has mastered the art of turning diagnoses into revenue.

• Risk adjustment model: CMS is continuing to use the 2024 Medicare Advantage risk adjustment model for 2027. It is not moving to the updated model it proposed in the advance notice, which would have been calibrated with more recent Original Medicare data. CMS frames this as giving the market more time to adjust after the phase-in of the 2024 model.
• Chart reviews: Starting in 2027, CMS is excluding diagnosis information from unlinked chart review records (diagnoses not tied to a specific encounter) from risk score calculations, with an exception for beneficiaries who switch from one Medicare Advantage organization to another.
• Audio-only: CMS is also finalizing the exclusion of diagnoses from audio-only encounters for risk score calculation.

The tradeoff: stability vs. clean receipts

Medicare Advantage is sold as choice. Sometimes it is. Sometimes it is a maze of prior authorization, narrow networks, and benefits that sparkle in October and quietly dim by March.

My centrist reality check: in a system serving tens of millions of older Americans, you cannot treat payment policy like a political mood ring. Wild swings invite plan exits and benefit cuts. But you also cannot keep sending more public money into a system if the oversight tools look like a 1997 civics textbook trying to regulate a 2026 revenue analytics department.

The Orwell check

CMS says the announcement “strengthens accountability” and supports “long-term sustainability.” Fine phrases. The question is whether they come with proof the public can actually see.

The liberty ledger

Seniors may gain stability. Plans and shareholders may gain, too. Taxpayers risk paying more without a clear, public, plan-by-plan receipt connecting dollars to outcomes. And when access to care depends on opaque internal processes and an appeal a senior does not know how to file, power is concentrated, not shared.

Guardrails before the next bump

If Medicare Advantage is getting paid more in 2027, the public should demand transparency that is readable, due process that is real, and oversight that people can trust. More money should come with more proof, out loud.